These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32490139)

  • 1. Impaired perfusion and capillary dysfunction in prodromal Alzheimer's disease.
    Nielsen RB; Parbo P; Ismail R; Dalby R; Tietze A; Brændgaard H; Gottrup H; Brooks DJ; Østergaard L; Eskildsen SF
    Alzheimers Dement (Amst); 2020; 12(1):e12032. PubMed ID: 32490139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Nielsen RB; Egefjord L; Angleys H; Mouridsen K; Gejl M; Møller A; Brock B; Brændgaard H; Gottrup H; Rungby J; Eskildsen SF; Østergaard L
    Alzheimers Dement; 2017 Oct; 13(10):1143-1153. PubMed ID: 28343848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of Tau Deposition and Microvascular Involvement in MCI and AD.
    Bryant AG; Manhard MK; Salat DH; Rosen BR; Hyman BT; Johnson KA; Huang S; Bennett RE; Yen YF
    Curr Alzheimer Res; 2021; 18(9):711-720. PubMed ID: 34825871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary function progressively deteriorates in prodromal Alzheimer's disease: A longitudinal MRI perfusion study.
    Madsen LS; Nielsen RB; Parbo P; Ismail R; Mikkelsen IK; Gottrup H; Østergaard L; Brooks DJ; Eskildsen SF
    Aging Brain; 2022; 2():100035. PubMed ID: 36908896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capillary dysfunction correlates with cortical amyloid load in early Alzheimer's disease.
    Madsen LS; Parbo P; Ismail R; Gottrup H; Østergaard L; Brooks DJ; Eskildsen SF
    Neurobiol Aging; 2023 Mar; 123():1-9. PubMed ID: 36610198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased cortical capillary transit time heterogeneity in Alzheimer's disease: a DSC-MRI perfusion study.
    Eskildsen SF; Gyldensted L; Nagenthiraja K; Nielsen RB; Hansen MB; Dalby RB; Frandsen J; Rodell A; Gyldensted C; Jespersen SN; Lund TE; Mouridsen K; Brændgaard H; Østergaard L
    Neurobiol Aging; 2017 Feb; 50():107-118. PubMed ID: 27951412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capillary dysfunction in healthy elderly APOE ε4 carriers with raised brain Aβ deposition.
    Madsen LS; Kjeldsen PL; Ismail R; Parbo P; Østergaard L; Brooks DJ; Eskildsen SF
    Alzheimers Dement; 2024 Jan; 20(1):459-471. PubMed ID: 37679610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of brain amyloid-β with cerebral perfusion and structure in Alzheimer's disease and mild cognitive impairment.
    Mattsson N; Tosun D; Insel PS; Simonson A; Jack CR; Beckett LA; Donohue M; Jagust W; Schuff N; Weiner MW;
    Brain; 2014 May; 137(Pt 5):1550-61. PubMed ID: 24625697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain perfusion in dementia with Lewy bodies and Alzheimer's disease: an arterial spin labeling MRI study on prodromal and mild dementia stages.
    Roquet D; Sourty M; Botzung A; Armspach JP; Blanc F
    Alzheimers Res Ther; 2016 Jul; 8():29. PubMed ID: 27401267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in vivo topography of cortical changes in healthy aging and prodromal Alzheimer's disease.
    Prestia A; Baglieri A; Pievani M; Bonetti M; Rasser PE; Thompson PM; Marino S; Bramanti P; Frisoni GB
    Suppl Clin Neurophysiol; 2013; 62():67-80. PubMed ID: 24053032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
    Huang SY; Zhang YR; Guo Y; Du J; Ren P; Wu BS; Feng JF; ; Cheng W; Yu JT
    Alzheimers Dement; 2024 May; 20(5):3251-3269. PubMed ID: 38501315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
    Mao C; You H; Hou B; Chu S; Jin W; Huang X; Shang L; Feng F; Peng B; Gao J
    J Alzheimers Dis; 2023; 93(2):509-519. PubMed ID: 37038812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging discrepancies between magnetic resonance imaging and brain perfusion single-photon emission computed tomography in the diagnosis of Alzheimer's disease, and verification with amyloid positron emission tomography.
    Yokoyama S; Kajiya Y; Yoshinaga T; Tani A; Hirano H
    Psychogeriatrics; 2014 Jun; 14(2):110-7. PubMed ID: 24954834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
    Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactive versus additive relationships between regional cortical thinning and amyloid burden in predicting clinical decline in mild AD and MCI individuals.
    d'Oleire Uquillas F; Jacobs HIL; Hanseeuw B; Marshall GA; Properzi M; Schultz AP; LaPoint MR; Johnson KA; Sperling RA; Vannini P
    Neuroimage Clin; 2018; 17():388-396. PubMed ID: 29159051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau.
    McCollum LE; Das SR; Xie L; de Flores R; Wang J; Xie SX; Wisse LEM; Yushkevich PA; Wolk DA;
    Neuroimage Clin; 2021; 31():102717. PubMed ID: 34119903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration.
    Levin F; Ferreira D; Lange C; Dyrba M; Westman E; Buchert R; Teipel SJ; Grothe MJ;
    Alzheimers Res Ther; 2021 Feb; 13(1):49. PubMed ID: 33608059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging.
    Lacalle-Aurioles M; Navas-Sánchez FJ; Alemán-Gómez Y; Olazarán J; Guzmán-De-Villoria JA; Cruz-Orduña I; Mateos-Pérez JM; Desco M
    J Alzheimers Dis; 2016; 50(4):1051-64. PubMed ID: 26890735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.